chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient states she usually gets really nervous and or dizzy with all shots and vaccines, Gave water and snack then she started to feel dizzy. Taken to room by wheelchair. She rested on cot for 10 minutes then said she was feeling okay. Sat on cot for 10 minutes then said she was ready to go and walked out with mother.  Discussed when she comes back for her second vaccine that we do the vaccine and observation  here instead. They agreed.
Breakthrough case of COVID, mild fever of 99 degrees, body aches, sore throat, heavy nasal discharge, headache, diarrhea, fatigue. The day I was diagnosed I got PAXLOVID for 5 days, June 20th -24th. I had an increasing return of symptoms on the 28th, and my first negative test was today 07/05/2022.
17 year old received vaccination; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old received vaccination) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old received vaccination). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old received vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant and treatment medication were provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Follow up received on 21-MAY-2021. No new information provided
Patient woke up the next morning with tender right neck. She states that it's swollen and a little painful to touch. Advised patient to take Ibuprofen and ice the affected area. Will follow up with patient for the next few days to see the outcome.
Fever for two days followed by persistent cough, lethargy, and shortness of breath that lasted approximately 8 weeks.  Rest and cough syrup for evenings and Tessalon Perles/inhaler to control cough during the day.
lymph nodes have swelled up in both arms (under both armpits); This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (lymph nodes have swelled up in both arms (under both armpits)) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (lymph nodes have swelled up in both arms (under both armpits)). At the time of the report, LYMPHADENOPATHY (lymph nodes have swelled up in both arms (under both armpits)) outcome was unknown. Not Provided          Concomitant medication was not reported. Treatment medication was not used.
Rash started one day after receiving flu vaccine. Benadryl was used x 1 day. Rash resolved after 2 days.
Had shot, now has shingles/suspected vaccination failure; Shingles bad; Pain; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had shot, now has shingles/suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles bad) and pain (Verbatim: Pain). The outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 09-MAR-2023 This case was reported by a patient via interactive digital media. The reporter reported that the patient received Shingles vaccine long time ago and now has shingles which bad and can not find anything to calm the pain. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
After administering vaccine with 1 inch needle, patient experienced a raised bump of fluid under the administration site. It appeared as if the fluid was subcutaneous. A 1 inch needle was appropriate for an intramuscular injection for this patient.
(R) thigh DTaP, MMR sites induration, warm 2cm x 2cm 24 hr after administration -Benadryl, ice, Tylenol
Pt is a 65 yo male with ESRD secondary to nephrolithiasis s/p kidney transplant with subsequent transplant failure due to BK viremia who presents to this institution on 4/11 for possible kidney transplant. He has been on HD with AVF for the last 2.5 years. No longer taking immunosuppression therapy as of 12/2020. He undergoes routine inpatient COVID-19 testing while admitted. Rapid testing comes back positive, whereas PCR testing comes back negative. Unclear if rapid test was false positive. Pt is s/p full Pfizer vaccination: first dose on 2/26 and second dose on 3/19.
8 days after vaccine, developed swelling redness and pain at injection site, spreading and more painful over next 24 hrs, treated for cellulitis with antibiotic
Local reaction at shot site with redness, induration, warm and tenderness 5cm x 7cm started 8 hours after immunization. Symptoms worsened till 48 hours after imm. then slowly started to improve. Treated with ice, Tylenol and then heat to area 72 hours later.
*Headache, neck and shoulder pain, joint pain (about a few hours after dose),  *fever ranging from 99.2 to 103.5, chills, sweats, nausea, and cough (started day 2) *injection site redness, swelling, and soreness, underarm inflammation and soreness ( about an hour after dose)
9/18/14 - vaccine given in left arm. 9/21 - very painful shoulder and severe loss of motion. Could not extend left arm up, out, to the side, across body or to the back. Low grade temp then up to 101 degrees F. 9/22, 23, 24 - 1 tablet ALEVE each day. Arm mobility returned slowly shoulder pain gone by 9/27.
Nothing at all for 14 hours...not even a sore arm. Around eleven that evening, severe headache; nausea; muscle aches arms & legs; and most serious two seizures (spasms??) about 5 seconds apart.  I?ve only had a few muscle cramps in my life so the seizures were unusual to say the least. They started in my lower abdomen (seemed like a small band going full circle around my body) and moved incrementally up towards my shoulders.  Rapid movement upward...kinda like squeezing a tube of toothpaste. Each one was only about two seconds long but fairly violent. If I had anything in stomach, it would have been on the floor.  Everything was gone (except the sore shoulder) by five in the morning.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) on or about 28-DEC-2015, prescribed by a physician and distributed at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent and chronic strain of herpes zoster. On or about 16-SEP-2016, the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as a severe case of herpes zoster, also known as shingles. The patient was also treated by another physician (date unknown) for ongoing and painful symptoms associated with shingles and resulting complications (unspecified). The patient was prescribed valacyclovir hydrochloride (VALTREX) for management of her painful and persistent symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
Wife described patient's symptoms as "stroke like." Experienced confusion, loss of coordination, confusion, loss bladder control, numbness and weakness in lower half of body, Patient did Not seek medical attention, wife states he slowly recovered back to normal after a few days. Never followed up with PCP or Pharmacy where he received the shot until now. Patient was present while we spoke and appeared normal and healthy. Patient apparently had a liver biopsy and a bone density test weekend prior to receiving booster shot.
DISCOMFORT IN JOINTS; This spontaneous report received from a patient concerned a 51 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Patient was Healthy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A expiry: UNKNOWN) dose was not reported, administered on 28-JUL-2021 for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, the patient experienced discomfort in joints. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of discomfort in joints was not reported. This report was non-serious. This case, involving the same patient is linked to 20211162035.
muscle breakdown; kidney failure; A Spontaneous report was recieved from a consumer concerning her mother a female patient who received Moderna's Covid-19 vaccine (mRNA-1273) and experienced muscle breakdown, kidney failure and hospitalized for 2 days.  The patient's medical history was not provided by the reporter.  On 12FEB2021,prior to the onset of the events, the patient received their first of two planned doses of mRNA-1237(Batch number: Unknown) route of administration( unknown) for prophylaxis of Covid-19 infection.  On 15FEB2021, three days after administration of vaccine the consumer stated that her mother developed muscle breakdown and kidney failure, and it resulted in hospitalization for 2 days.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of event muscle breakdown, kidney failure were considered to be not recovered or not resolved,; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.
Patient received Pfizer COVID 19 vaccine last Thursday 12/17. Admitted today (12/21) with bleeding and low platelet count - working up for ITP, TTP. Given recency of vaccination and no known contributory allergy or medical history, physician thought potentially associated with vaccination.
Patient reports onset of general weakness 4 days after administration of vaccine. Weakness gradually progressed to the point of inability to walk and, eventually, stand. Weakness became associated with limb rigidity. Amid these events, patient became febrile and this prompted presentation to the hospital where he was admitted with acute illness presumed to be secondary to pneumonia.
The pt developed screaming, inconsolable cry for 2 1/2-3 hours.
nightmares; brain feels compromised; This spontaneous case was reported by a consumer and describes the occurrence of NIGHTMARE (nightmares) and CEREBRAL DISORDER (brain feels compromised) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NIGHTMARE (nightmares) and CEREBRAL DISORDER (brain feels compromised). At the time of the report, NIGHTMARE (nightmares) and CEREBRAL DISORDER (brain feels compromised) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       At night he has very weird and bad dreams especially on his diabetes medication.No treatment information was provided.
Rash (two papular erythematous patches to L upper arm with small clustered vesicles, smaller patch on back of left hand); couple pearly, flesh colored papules to R upper arm. Asymmetrical vesicular appearance somewhat suspicious for shingles, though would be atypical for age. Discussed contact dermatitis most likely cause. Recommend treating presumptively. Will reach out to dermatology as well.
-moderate-severe back pain, what I can describe as "bone pain." My spine was hurting so bad I couldn't bear to sit up on my couch and had to lie in bed; lasted until about 24 hours after the vaccine -chest pain- lasted about 24 hours after the vaccine  -lethargy/fatigue- I was so tired I slept most of the day.lasted about 24 hours after the vaccine -general weakness- lasted about 3 days after the vaccine -Sore left deltoid muscle (injection site) lasted about 3-4 days after the vaccine -swollen left deltoid muscle- lasted about 48 hours after the vaccine -nasal inflammation- lasted about 24-48 hours after the vaccine. No drainage noted, only inflammation -decreased appetite- about 3-4 days after the vaccine. I forced myself to eat one meal a day and almost threw up after -nausea after eating/food aversion -3-4 days after the vaccine -Feeling feverish/having chills- I could not check my temp to see if I had an actual fever, but my body felt hot, I had chills, and on the second day, I woke up in a sweat and felt as if a fever had "broke." -a sense of impending doom/something wasn't right -difficulty breathing/pain when inhaling- made it difficult to speak, was winded from walking up my stairs in my apartment. Lasted about 24 hours after the vaccine.  -Sore throat-- lasted about 24 hours after the vaccine
pt vaxed 24JUL95 & 16AUG95 exp rash  w/50 lesions, T101, nausea & swelling @ inj site;pt seen by MD & taken to ER;5pound weight loss noted;blood sugar 200 in morning & 80 in evening w/high ketones;dx chicken pox;tingling, itching-dx shingle
Redness, swelling, and pain surrounding injection site. Redness from right shoulder to right elbow and warm to touch.
Tingling lip; Numb arm; Weakness; Fever of 101 degrees; Heart racing; Sweating; Diarrhea; Very ill; Completely wiped out; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Jan-2021 and was forwarded to Moderna on 15-Jan-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA ORAL (Tingling lip), HYPOAESTHESIA (Numb arm), ASTHENIA (Weakness), PYREXIA (Fever of 101 degrees) and PALPITATIONS (Heart racing) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).    On 12-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 13-Jan-2021, the patient experienced FATIGUE (Completely wiped out). On an unknown date, the patient experienced PARAESTHESIA ORAL (Tingling lip), HYPOAESTHESIA (Numb arm), ASTHENIA (Weakness), PYREXIA (Fever of 101 degrees), PALPITATIONS (Heart racing), HYPERHIDROSIS (Sweating), DIARRHOEA (Diarrhea) and MALAISE (Very ill). At the time of the report, PARAESTHESIA ORAL (Tingling lip), HYPOAESTHESIA (Numb arm), ASTHENIA (Weakness), PYREXIA (Fever of 101 degrees), PALPITATIONS (Heart racing), HYPERHIDROSIS (Sweating), DIARRHOEA (Diarrhea), FATIGUE (Completely wiped out) and MALAISE (Very ill) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Pyrexia: 101 degrees 101 degrees.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment with bupropion and estradiol patch was reported. HCP told the patient to in isolation for 3 days
Patient received vaccine 10 days after the beyond  use date. Beyond use date was on 11/20/2021. re vaccinate scheduled on 2/1/2022
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Nov-2021 at 4:39 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 16-Nov-2021 at 4:39 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  The patient was given a dose from a vial that was stored in an ultracold freezer which was colder than they should have been.  No treatment information was provided.
This 56-year-old pt was diagnosed with COVID 3/7 and was brought to the ER because of issues with respiratory difficulties at home. Pt was diagnosed with PE, started on anticoagulation with IV heparin.  During hospitalization, the patient had episodes of agitation and was not cooperative.  Due to her underlying developmental delay as well as mental retardation.  The patient was managed with IV fluids, antibiotics, and anticoagulation.  As her respiratory condition stabilized, she was sent back home with following medication, followup with home visiting physician in a stable condition on 3/10.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown ages and gender. On an unknown dates the patients were vaccinated with a dose of GARDASIL (dose, route, and lot number not provided) that was improperly stored and exposed to temperatures outside the storage range in the prescribing information. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Add:Hx of anaphylaxis. Reported hives and nausea after first shot. Did not receive 2nd shot. Unknown referral plan.
feeling unwell; headache; nausea; fever/ temperature the first night; lethargic; muscle pain; insomnia; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of feeling bad in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced feeling bad (Verbatim: feeling unwell), headache (Verbatim: headache), nausea (Verbatim: nausea), fever (Verbatim: fever/ temperature the first night), lethargy (Verbatim: lethargic), muscle pain (Verbatim: muscle pain) and insomnia (Verbatim: insomnia). The outcome of the feeling bad, headache, nausea, fever, lethargy, muscle pain and insomnia were unknown.   It was unknown if the reporter considered the feeling bad, headache, nausea, fever, lethargy, muscle pain and insomnia to be related to Shingles vaccine.     It was unknown if the company considered the feeling bad, headache, nausea, fever, lethargy, muscle pain and insomnia to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 12-Apr-2023 The patient got the first vaccine and felt bad for more than 4 days, headache, nausea, temperature the first night, lethargy, muscle pain, insomnia but, it was nothing compared to what people who do not get vaccinated suffer. The reporter had seen it in relatives, and it was not pleasant at all. The patient going for the 2nd vaccine 2 months later.
Patient woke up morning of 10/17 and noticed her left arm was red, swelling and a little itchy. She stated she doesn't know when it started but 10/17 was when she noticed it.
Redness, nausea, headache, muscle ache, fatigue, warmth to vaccine site and hurt to lift arm.